Prometheus Biosciences, Inc. Alternatives & Competitors

12 companies similar to Prometheus Biosciences, Inc. — Revolutionizing medicine with precision.

Mirador Therapeutics

Redefining Immunology and Inflammation with Precision

95 Series B $650.00M

Biotechnology Health Care +1

Crescendo Bioscience

Empowering rheumatologists with precise diagnostic tools for autoimmune and inflammatory d...

1001-5000 Series D $141.68M

Biotechnology Health Care

Alumis

Transforming the lives of patients living with immune-mediated diseases using a precision...

249 Series C $529.00M

South San Francisco, Unit...

Biotechnology Health Care +1

ADARx Pharmaceuticals Inc.

Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...

94 Series C $327.00M

San Diego, United States

Biotechnology Health Care +1

Track all Prometheus Biosciences, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Siolta Therapeutics

16 Series C $42.00M

San Carlos, United States

Biotechnology Health and Wellness

SeqOne

From Genome to Personalized Medicine

108 Venture round $43.00M

Montpellier, France

Analytics Big Data +2

Gossamer Bio

Vision * Connection * Innovation

159 Post-IPO Equity $812.00M

San Diego, United States

Biotechnology Health Care +1

HI-Bio: A Biogen Company

HI-Bio is a clinical-stage biotech company delivering targeted therapies for patients with...

22 Acquired $1.37B

South San Francisco, Unit...

Biotechnology Health and Wellness +1

Lexeo Therapeutics

Advancing science with curative potential for both cardiovascular and APOE4 associated Alz...

97 Post-IPO Equity $280.00M

New York, United States

Biotechnology Health and Wellness +1

Affinivax Inc.

23 Grant $377.49M

Cambridge, United States

Biotechnology Health Care +1

Parabilis Medicines

We are dedicated to creating extraordinary medicines for people affected by serious diseas...

197 Series F+ $808.40M

Cambridge, United States

Biotechnology Pharmaceutical

CNine Biosolutions

Advancing diagnostic precision through the uncharted potential of the complement system in...

2-10 Seed $2.00M

Biotechnology Health Care

About Prometheus Biosciences, Inc.

Prometheus Biosciences, Inc. is a clinical-stage biotechnology company that is revolutionizing medicine with precision. The company, founded in 1995, is listed on Nasdaq under the ticker symbol RXDX.

Taxonomy

Precision Medicine, Clinical-stage, Companion Diagnostics, Bioinformatics, Gastrointestinal Diseases, Therapeutic Targets, Immune-mediated Diseases, Diagnostic Products, Pharmaceutical Development, San Diego, Clinical Remission, Immunology

Frequently Asked Questions

Companies similar to Prometheus Biosciences, Inc. include Mirador Therapeutics, Crescendo Bioscience, Alumis, ADARx Pharmaceuticals Inc., Siolta Therapeutics. They work in Biotechnology and Health Care and share Prometheus Biosciences, Inc.'s focus on precision medicine, immunology and companion diagnostics.

Bounce Watch lists 12 companies that share Prometheus Biosciences, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Prometheus Biosciences, Inc. is a clinical-stage biotechnology company that is revolutionizing medicine with precision. The company, founded in 1995, is listed on Nasdaq under the ticker symbol RXDX.

Don't just read about them. Follow them.

BounceWatch watches Prometheus Biosciences, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Prometheus Biosciences, Inc. Profile Alumis Alternatives ADARx Pharmaceuticals Inc. Alternatives Siolta Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Prometheus Biosciences, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.